In Journal of mass spectrometry and advances in the clinical lab
Mass spectrometry focusing on small endogenous molecules has become an integral part of biomarker discovery in the pursuit of an in-depth understanding of the pathophysiology of various diseases, ultimately enabling the application of personalized medicine. While LC-MS methods allow researchers to gather vast amounts of data from hundreds or thousands of samples, the successful execution of a study as part of clinical research also requires knowledge transfer with clinicians, involvement of data scientists, and interactions with various stakeholders. The initial planning phase of a clinical research project involves specifying the scope and design, and engaging relevant experts from different fields. Enrolling subjects and designing trials rely largely on the overall objective of the study and epidemiological considerations, while proper pre-analytical sample handling has immediate implications on the quality of analytical data. Subsequent LC-MS measurements may be conducted in a targeted, semi-targeted, or non-targeted manner, resulting in datasets of varying size and accuracy. Data processing further enhances the quality of data and is a prerequisite for in-silico analysis. Nowadays, the evaluation of such complex datasets relies on a mix of classical statistics and machine learning applications, in combination with other tools, such as pathway analysis and gene set enrichment. Finally, results must be validated before biomarkers can be used as prognostic or diagnostic decision-making tools. Throughout the study, quality control measures should be employed to enhance the reliability of data and increase confidence in the results. The aim of this graphical review is to provide an overview of the steps to be taken when conducting an LC-MS-based clinical research project to search for small molecule biomarkers.
Rischke S, Hahnefeld L, Burla B, Behrens F, Gurke R, Garrett T J
2023-Apr
(U)HPLC (Ultra-), High pressure liquid chromatography, Biomarker Discovery Study, HILIC, Hydrophilic interaction liquid chromatography, HRMS, High resolution mass spectrometry, LC-MS, Liquid chromatography – mass spectrometry, LC-MS-Based Clinical Research, Lipidomics, MRM, Multiple reaction monitoring, Metabolomics, PCA, Principal component analysis, QA, Quality assurance, QC, Quality control, RF, Random Forest, RP, Reversed phase, SVA, Support vector machine
